17beta-HSD10-IN-2 (compound 11), a benzothiazolylurea-based inhibitor, specifically targets 17beta-hydroxysteroid dehydrogenase type 10 (17beta-HSD10), avoiding mitochondrial off-targets and cytotoxic or neurotoxic effects. This multifunctional mitochondrial enzyme inhibitor has potential applications in Alzheimers disease (AD) and hormone-dependent cancer research [1].
Molekulargewicht:
363.78
CAS Nummer:
[2316765-79-2]
Formel:
C15H10ClN3O4S
Target-Kategorie:
Endogenous Metabolite
T79459
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten